Danish firm Bavarian Nordic A/S has announced that Singapore’s medicines regulatory authority, Health Sciences Aut...
A new facility at The University of Queensland (UQ) is set to provide Australian researchers with cancer vaccines tailor...
Korea's Ministry of Health and Welfare and the Korea Health Industry Development Institute (KHIDI) recent...
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a Simple Agreement for F...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and French biotech firm Valneva SE, have expanded th...
Mélanie Joly, Canada’s Minister of Foreign Affairs, visited the International Vaccine Institute’s (IV...
Indian Immunologicals Ltd (IIL), led by its Chairman Dr Meenesh Shah and Managing Director Dr K. Anand Kumar, has donate...
Moderna, Inc. and Mitsubishi Tanabe Pharma Corporation have entered into a joint agreement regarding the co-promot...
Merck, a leading science and technology company, has announced that its life science business sector has entered a...
South Korea-based International Vaccine Institute (IVI) has signed a memorandum of understanding (MoU) with the Catholic...
Gavi, the Vaccine Alliance, in collaboration with partners, has announced support for human rabies vaccines for post exp...
The International Vaccine Institute (IVI) has exchanged a trilateral Memorandum of Understanding (MoU) with the Korea Ad...
Queensland will be a major international hub for vaccine discovery and development with a $32 million partnership secure...
A scientific team from the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine) and Mo...
Bavarian Nordic A/S and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced a partnership to advan...
Singapore's Ministry of Health has announced that Novavax/Nuvaxovid XBB.1.5 COVID-19 vaccine will be available under the...
Under the esteemed patronage of the Ministry of National Guard Health Affairs, represented by the Infection Prevent...
GSK's Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for...
